Clorox (NYSE:CLX – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50, Briefing.com reports. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business earned $0.49 EPS. The company’s revenue was up 27.0% compared to the same quarter last year. Clorox updated its FY25 guidance to $6.65-$6.90 EPS and its FY 2025 guidance to 6.650-6.900 EPS.
Clorox Stock Performance
NYSE CLX traded up $4.11 during trading on Thursday, reaching $160.62. The company’s stock had a trading volume of 1,792,168 shares, compared to its average volume of 1,229,622. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The firm has a market capitalization of $19.95 billion, a price-to-earnings ratio of 81.12, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. Clorox has a 12 month low of $114.68 and a 12 month high of $169.09. The firm has a 50 day moving average price of $161.14 and a 200 day moving average price of $145.90.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on Clorox
Insider Buying and Selling at Clorox
In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.51% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- Technology Stocks Explained: Here’s What to Know About Tech
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- How to Invest in the Best Canadian Stocks
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.